4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000116
Chief Legal Officer sold 9,050 shares at an average $24.94 ($225,736)
- Chief Legal Officer acquired 9,050 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ring Christine · Chief Legal Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,760 | $1.86 | $10,714 | 30,352 | D |
| 2024-09-03 | Exercise or conversion : show line 2 in the form 10b5-1 | +3,290 | $9.57 | $31,485 | 33,642 | D |
| 2024-09-03 | Sale : show line 3 in the form 10b5-1 | −8,850 | $24.93 | $220,612 | 24,792 | D |
| 2024-09-03 | Sale : show line 4 in the form 10b5-1 | −200 | $25.62 | $5,124 | 24,592 | D |
| Open-market sales · 9,050 sh · avg $24.94 · $225,736 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-03 | Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (right to buy) | −5,760 | 77,026 | D |
| 2024-09-03 | Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (right to buy) | −3,290 | 102,969 | D |
Loading xslF345X05/wk-form4_1725399182.xml…